Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A comparative analysis of cytochrome P450 activities in paired liver and small intestinal samples from patients with obesity.

Krogstad V, Peric A, Robertsen I, Kringen MK, Wegler C, Angeles PC, Hjelmesaeth J, Karlsson C, Andersson S, Artursson P, Asberg A, Andersson TB, Christensen H.

Drug Metab Dispos. 2019 Nov 4. pii: dmd.119.087940. doi: 10.1124/dmd.119.087940. [Epub ahead of print]

2.

The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.

Angeles PC, Robertsen I, Seeberg LT, Krogstad V, Skattebu J, Sandbu R, Åsberg A, Hjelmesaeth J.

Obes Rev. 2019 Sep;20(9):1299-1311. doi: 10.1111/obr.12869. Epub 2019 Jun 24. Review.

PMID:
31232513
3.

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL).

Hjelmesæth J, Åsberg A, Andersson S, Sandbu R, Robertsen I, Johnson LK, Angeles PC, Hertel JK, Skovlund E, Heijer M, Ek AL, Krogstad V, Karlsen TI, Christensen H, Andersson TB, Karlsson C.

BMJ Open. 2018 May 29;8(5):e021878. doi: 10.1136/bmjopen-2018-021878.

4.

Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies.

Krogstad V, Vethe NT, Robertsen I, Hasvold G, Ose AD, Hermann M, Andersen AM, Chan J, Skauby M, Svensson MHS, Åsberg A, Christensen H.

Ther Drug Monit. 2018 Jun;40(3):292-300. doi: 10.1097/FTD.0000000000000510.

PMID:
29578937

Supplemental Content

Loading ...
Support Center